– Reuters
Truist Securities Maintains Hold on Gilead Sciences, Raises Price Target to $76
Truist Securities analyst Robyn Karnauskas maintains Gilead Sciences (NASDAQ:GILD) with a Hold and raises the price target from $71 to $76.
Related Posts
What’s Going On With Virgin Galactic Holdings Stock?
Virgin Galactic Holdings, Inc. (NYSE: SPCE) shares are trading lower Thursday.
X Has Bad Timing With Tech Issues Thursday After Rival Threads Reports 100M Users: Inside The Struggles Of Elon Musk’s Company In 2023
Tweets weren't visible Thursday morning while Thread reports 100 million users.
Cornhole Among ‘Fastest Growing Sports’ And Official Gear Is About To Flood Stores
Escalade Inc (NASDAQ:ESCA) has signed a long-term licensing partnership with the governing body for professional, competitive, and recreational cornhole, American Cornhole League (ACL).…